Randomized trial to study the effect of ursodeoxycholic acid versus placebo in interpretation of myocardial perfusion scintigraphy
Phase 3
Completed
- Conditions
- Health Condition 1: I258- Other forms of chronic ischemic heart disease
- Registration Number
- CTRI/2017/08/009506
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
known or suspected coronary artery disease patients
Exclusion Criteria
1. Less than 18 years
2.Patient not willing to give the consent
3.Any patient with contraindication to use UDCA as interventional drug eg. gall stone disease, gall bladder inflammation, biliary tract occlusion, biliary colic and hypersenstivity to the drug etc.
4.Patient with hepatic disorder affecting the tracer uptake
5.Pregnant and lactating female patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method